SEARCH

SEARCH BY CITATION

References

  • Allen J. W., Ivanova S. A., Fan L., Espey M. G., Basile A. S. and Faden A. I. (1999) Group II metabotropic glutamate receptor activation attenuates traumatic neuronal injury and improves neurological recovery after traumatic brain injury. J. Pharmacol. Exp. Ther. 290, 112120.
  • Aronica E., Gorter J. A., Ijlst-Keizers H., Rozemuller A. J., Yankaya B., Leenstra S. and Troost D. (2003) Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins. Eur. J. Neurosci. 17, 21062118.DOI: 10.1046/j.1460-9568.2003.02657.x
  • Badar-Goffer R., Bachelard H. and Morris P. (1990) Cerebral metabolism of acetate and glucose studied by 13C NMR spectroscopy. Biochem. J. 266, 133139.
  • Badar-Goffer R., Bachelard H. and Morris P. (1992) Neuronal-glial metabolism under depolarising conditions. Biochem. J. 282, 225230.
  • Bao W. L., Williams A. J., Faden A. I. and Tortella F. C. (2001) Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia. Brain Res. 922, 173179.
  • Battaglia G., Bruno V., Pisani A., Centonze D., Catania M. V., Calabresi P. and Nicoletti F. (2001) Selective blockade of type-I metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission. Mol. Cell. Neurosci. 17, 10711083.
  • Bordi F. and Ugolini A. (1999) Group I metabotropic glutamate receptors: implications for brain diseases. Prog. Neurobiol. 59, 5579.
  • Brabet I., Parmentier M.-L., De Colle C., Bockaert J., Acher F. and Pin J.-P. (1998) Comparative effect of L-CCG-I, DCG-IV and γ-carboxy-l-glutamate on all cloned metabotropic glutamate receptor subtypes. Neuropharmacology 37, 10431051.
  • Bruno V., Battaglia G., Copani A., D'onofrio M., Di Iorio P., De Blasi A., Melchiorri D., Flor P. J. and Nicoletti F. (2001) Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J. Cereb. Blood Flow Metab. 21, 10131033.
  • Cartmell J. and Schoepp D. D. (2000) Regulation of neurotransmitter release by metabotropic glutamate receptors. J. Neurochem. 75, 889907.
  • Cartmell J., Adam G., Chaboz S. et al. (1998) Characterization of [3H]-(2S,2′R,3′R)-2-(2′,3′-dicarboxy-cyclopropyl) glycine ([3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes. Br. J. Pharmacol. 123, 497504.
  • Cozzi A., Meli E., Carla V., Pellicciari R., Moroni F. and Pellegrini-Gianpietro D. E. (2002)Metabotropic glutamate 1 (mGlu 1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attentuation of post-ischemic injury and epileptiform activity? Neuropharmacology 43, 119130.
  • Doherty A. J., Palmer M. J., Henley J. M., Collingridge G. L. and Jane D. E. (1997) (RS)-2-Chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but not mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology 36, 265267.DOI: 10.1016/S0028-3908(97)00001-4
  • Drew G. M. and Vaughan C. W. (2004) Multiple metabotropic glutamate receptor subtypes modulate GABAergic neurotransmission in rat periaqueductal grey neurons in vitro. Neuropharmacology 46, 927934.DOI: 10.1016/j.neuropharm.2004.01.015
  • Fazal A., Parker F., Palmer A. M. and Croucher M. J. (2003) Characterization of the actions of group I metabotropic glutamate receptor subtype selective ligands on excitatory amino acid release and sodium-dependent re-uptake in rat cerebrocortical minislices. J. Neurochem. 86, 13461358.DOI: 10.1046/j.1471-4159.2003.01932.x
  • Griffin J. L., Rae C., Radda G. K. and Matthews P. M. (1999) Delayed labelling of brain glutamate after an intra-arterial [13C]glucose bolus: evidence for aerobic metabolism of guinea pig brain glycogen store. Biochim. Biophys. Acta 1450, 297307.DOI: 10.1016/S0167-4889(99)00067-1
  • Guérineau N. C., Bossu J. L., Gahwiler B. H. and Gerber U. (1995) Activation of a nonselective cationic conductance by metabotropic glutamatergic and muscarinic agonists in CA3 pyramidal neurons of the rat hippocampus. J. Neurosci. 15, 43954407.
  • Ichord R. N., Johnston M. V. and Traystman R. J. (2001) MK801 decreases glutamate release and oxidative metabolism during hypoglycemic coma in piglets. Dev. Brain Res. 128, 139148.DOI: 10.1016/S0165-3806(01)00161-4
  • Jane D. E., Thomas N. K., Tse H.-W. and Watkins J. C. (1996) Potent antagonists at the L-AP4 and (1S,3S)-ACPD-sensitive presynaptic metabotropic glutamate receptors in the neonatal rat spinal cord. Neuropharmacology 35, 10291035.DOI: 10.1016/S0028-3908(96)00048-2
  • Kupce E. and Freeman R. (1995) Adiabatic pulses for wideband inversion and broadband decoupling. J. Magn. Reson. A 115, 273276.DOI: 10.1006/jmra.1995.1179
  • Kwak S., Miyamoto M., Ishida M. and Shinozaki H. (1996) Neurotoxicity of (2S,1′R,2′R,3′R)-2-(2,3-dicarboxycyclopropyl) glycine, a potent agonist for class II metabotropic glutamate receptors, in the rat. Neuroscience 73, 687695.DOI: 10.1016/0306-4522(96)00043-7
  • Lieb I., Chebib M., Cooper B., Dias L. S. and Balcar V. J. (2000) Quantitative autoradiography of Na+-dependent [3H]l-aspartate binding to l-glutamate transporters in rat brain: structure-activity studies using 1-trans-pyrrolidine-2,4-dicarboxylate (l-t-PDC) and 3-(carboxycyclopropyl)-glycine (CCG). Neurochem. Int. 36, 319327.DOI: 10.1016/S0197-0186(99)00140-0
  • Lujan R., Nusser Z. J. D. R., Shigemoto R. and Somogyi P. (1996) Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur. J. Neurosci. 8, 14881500.
  • Ma D., Tian H., Sun H., Kozikowshi A. P., Pshenichkin S. and Wroblewski J. T. (1997) Synthesis and biological activity of cyclic analogues of MPPG and MCPG as metabotropic glutamate receptor antagonists. Bioorg. Med. Chem. Lett. 7, 11951198.DOI: 10.1016/S0960-894X(97)00177-7
  • McIlwain H. and Bachelard H. (1985) Biochemistry and the Central Nervous System. Churchill Livingstone, Edinburgh.
  • Moldrich R. X., Giardina S. F. and Beart P. M. (2001) Group II mGlu receptor agonists fail to protect against various neurotoxic insults induced in murine cortical, striatal and cerebellar granular pure neuronal cultures. Neuropharmacology 41, 1931.DOI: 10.1016/S0028-3908(01)00045-4
  • Moroni F., Lombardi G., Thomsen C., Leonardi P., Attuci S., Peruginelli F., Torregrossa S. A., Pellegrini-Gianpietro D. E., Luneia R. and Pellicciari R. (1997) Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent MGluR1 antagonist. J. Pharmacol. Exp. Ther. 28, 721729.
  • Moussa C. E.-H., Mitrovic A. D., Vandenberg R. J., Provis T., Rae C., Bubb W. A. and Balcar V. J. (2002) Effects of l-glutamate transport inhibition by a conformationally restricted glutamate analogue (2S,1′S,2′R)-2-(carboxycyclopropyl) glycine (L-CCG III) on metabolism in brain tissue in vitro analysed by NMR spectroscopy. Neurochem. Res. 27, 2735.DOI: 10.1023/A:1014842303583
  • Mutel V., Adam G., Chaboz S., Kemp J. A., Klingelschmidt A., Messer J., Wichmann J., Woltering T. and Richards J. G. (1998) Characterization of (2S,2′R,3′R)-2-(2′,3′-[3H]-dicarboxycyclopropyl) glycine binding in rat brain. J. Neurochem. 71, 25582564.
  • Nakanishi S. (1992) Molecular diversity of glutamate receptors and implications for brain function. Science 258, 597603.
  • Neki A., Ohishi H., Kaneko T., Shigemoto R., Nakanishi S. and Mizuno N. (1996) Pre- and postsynaptic localisation of a metabotropic glutamate receptor, mGluR2, in the rat brain: an histochemical study with a monoclonal antibody. Neurosci. Lett. 502, 197200.DOI: 10.1016/0304-3940(95)12248-6
  • Nicoletti F., Bruno V., Catania M. V., Battaglia G., Copani A., Barbagallo G., Ceña V., Sanchez-Prieto J., Spano P. F. and Pizzi M. (1999) Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection. Neuropharmacology 38, 14771484.DOI: 10.1016/S0028-3908(99)00102-1
  • Ohishi H., Ogawa-Megura R., Shigemoto R., Kaneko T., Nakanishi S. and Mizuno N. (1994) Immunohistochemcial localisation of metabotropic glutamate receptors, mGluR2 and mGluR3, in rat cerebellar cortex. Neuron 13, 5566.DOI: 10.1016/0896-6273(94)90459-6
  • Ong W. Y. and Balcar V. J. (1997) Group I metabotropic glutamate receptor agonist causes neurodegeneration in rat hippocampus. J. Hirnforsch 3, 317322.
  • Pellegrini-Giampietro D. E., Cozzi A., Peruginelli F., Leonardi P., Meli E., Pellicciari R. and Moroni F. (1999) 1-Aminoindan-1,5-dicarboxylic acid and (S)-(+)-2-(3′-carboxybicyclo[1.1.1] pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischaemia. Eur. J. Neurosci. 11, 36373647.DOI: 10.1046/j.1460-9568.1999.00786.x
  • Pellicciari R., Luneia R., Constantino G., Marinozzi M., Natalini B., Jakobsen P., Kanstrup A., Lombardi G., Moroni F. and Thomsen C. (1995) 1-Aminoindan-1,5-dicarboxylic acid: a novel antagonist of phospholipase C-linked metabotropic glutamate receptors. J. Med. Chem. 38, 37173719.
  • Pisani A., Calabresi P., Centonze D. and Bernardi G. (1997) Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones. Br. J. Pharmacol. 120, 10071014.
  • Pliss L., FitzGibbon T., Balcar V. J. and Stastny F. (2000) Neurotoxicity of NAAG in vivo is sensitive to NMDA antagonists and mGluR II ligands. Neuroreport 11, 36513654.
  • Pliss L., Balcar V. J., Bubenikova V., Pokorny J., Fitzgibbon T. and Stastny F. (2003) Morphology and ultrastructure of rat hippocampal formation after i.c.v. administration of N-acetyl-l-aspartyl-l-glutamate. Neuroscience 122, 93101.DOI: 10.1016/S0306-4522(03)00550-5
  • Rae C., Lawrance M. L., Dias L. S., Provis T., Bubb W. A. and Balcar V. J. (2000) Strategies for studies of potentially neurotoxic mechanisms involving deficient transport of l-glutamate: antisense knockout in rat brain in vivo and changes in the neurotransmitter metabolism following inhibition of glutamate transport in guinea pigs brain slices. Brain Res. Bull. 53, 373381.DOI: 10.1016/S0361-9230(00)00372-5
  • Rae C., Blair D. H., Griffin J. L., Bothwell J. H. F., Bubb W. A., Maitland A. and Head S. (2002) Brain biochemical abnormalities associated with lack of dystrophin; studies in the mdx mouse. Neuromusc. Disord. 12, 121129.DOI: 10.1016/S0960-8966(01)00253-X
  • Rae C., Hare N., Bubb W. A., McEwan S. R., Bröer A., McQuillan J. A., Balcar V. J., Conigrave A. D. and Bröer S. (2003) Inhibition of glutamine transport depletes glutamate and GABA neurotransmitter pools: further evidence for metabolic compartmentation. J. Neurochem. 85, 503514.
  • Sagara Y. and Schubert D. (1998) The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress. J. Neurosci. 18, 16626671.
  • Saransaari P. and Oja S. S. (2003) Characteristics of GABA release modified by glutamate receptors in mouse hippocampal slices. Neurochem. Int. 43, 453459.DOI: 10.1016/S0197-0186(03)00034-2
  • Schoepp D. D., Goldsworthy J., Johnson B. G., Salhoff C. R. and Baker S. R. (1994) 3,5-Dihydroxyphenylglycine is a highly selective agonist for phosphoinositide-linked metabotropic glutamate receptors in the rat hippocampus. J. Neurochem. 63, 769772.
  • Schoepp D. D., Jane D. E. and Monn J. A. (1999) Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 38, 14311476.DOI: 10.1016/S0028-3908(99)00092-1
  • Shank R. P., Leo G. C. and Zielke H. R. (1993) Cerebral metabolic compartmentation as revealed by nuclear magnetic resonance analysis of d-[1–13C]glucose metabolism. J. Neurochem. 61, 315323.
  • Shave E., Pliss L., Lawrance M. L., FitzGibbon T., Stastny F. and Balcar V. J. (2001) Regional distribution and pharmacological characteristics of [3H]N-acetyl-aspartyl-glutamate (NAAG) binding sites in rat brain. Neurochem. Int. 38, 5362.DOI: 10.1016/S0197-0186(00)00045-0
  • Shigemoto R., Nomura S., Ohishi H., Sagihara H., Nakanishi S. and Mizuno N. (1993) Immunohistochemical localisation of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci. Lett. 163, 5357.DOI: 10.1016/0304-3940(93)90227-C
  • Sibson N. R., Mason G. F., Shen J., Cline G. W., Herskovits A. Z., Wall J. E. M., Behar K. L., Rothman D. L. and Shulman R. G. (2001) In vivo13C NMR measurement of neurotransmitter glutamate cycling, anaplerosis and TCA cycle flux in rat brain during [2-13C]glucose infusion. J. Neurochem. 76, 975989.DOI: 10.1046/j.1471-4159.2001.00074.x
  • Skinner T. E. and Bendall M. R. (1997) A phase-cycling algorithm for reducing sidebands in adiabatic decoupling. J. Magn. Reson. 124, 474478.DOI: 10.1006/jmre.1996.1061
  • Slusher B. S., Vornov J. J., Thomas A. G. et al. (1999) Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nat. Med. 5, 13961402.DOI: 10.1038/70971
  • Smolders I., Lindekens H., Clinckers R., Meurs A., O'Neill M. J., Lodge D., Ebinger G. and Michotte Y. (2004) In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligands. J. Neurochem. 88, 10681077.DOI: 10.1046/j.1471-4159.2003.02251.x
  • Snyder E. M., Philpot B. D., Huber K. M., Dong X., Fallon J. R. and Beal M. F. (2001) Internalisation of ionotropic glutamate receptors in response to mGluR activation. Nat. Neurosci. 4, 10791086.DOI: 10.1038/nn746
  • Stanton D., Liao L. P., Moussa C. E.-H., Rae C., Bubb W. A. and Balcar V. J. (2003) Can inhibition of glutamate transport contribute to the action of neuroleptics? Psychaitrie (Prague) 7, 611.
  • Strasser U., Lobner D., Behrens M. M., Canzoniero L. M. and Choi D. W. (1998) Antagonists for group I mGluRs attentuate excitotoxic neuronal death in cortical cultures. Eur. J. Neurosci. 1998, 28482855.DOI: 10.1046/j.1460-9568.1998.00291.x
  • Strijbos P. J., Leach M. J. and Garthwaite J. (1996) Vicious cycle involving Na+ channels, glutamate release, and NMDA receptors mediates delayed neurodegeneration through nitric oxide formation. J. Neurosci. 16, 50045013.
  • Thomas A. G., Olkowski J. L. and Slusher B. S. (2001) Neuroprotection afforded by NAAG and NAALADase inhibition requires glial cells and metabotropic glutamate receptor activation. Eur. J. Pharmacol. 426, 3538.DOI: 10.1016/S0014-2999(01)01198-0
  • Uyama Y., Ishida M. and Shinozaki H. (1997) DCG-IV, a potent metabotropic glutamate receptor agonist, as an NMDA receptor agonist in the rat cortical slice. Brain Res. 752, 327330.DOI: 10.1016/S0006-8993(97)00079-6
  • Venero J. L., Santiago M., Tomas-Camardiel M., Matarredona E. R., Cano J. and Machado A. (2002) DCG-IV but not other group-II metabotropic receptor agonists induces microglial BDNF mRNA expression in the rat striatum. Correlation with neuronal injury. Neuroscience 113, 857869.DOI: 10.1016/S0306-4522(02)00232-4
  • Waagepetersen H. S., Sonnewald U., Larsson O. M. and Schousboe A. (2001) Multiple compartments with different metabolic characteristics are involved in biosynthesis of intracellular and released glutamine and citrate in astrocytes. Glia 35, 246252.DOI: 10.1002/glia.1089
  • Willker W., Leibfritz D., Kerssebaum R. and Bermel W. (1993) Gradient selection in inverse heteronuclear correlation spectroscopy. Magn. Reson. Chem. 31, 287292.
  • Wilsch V. W., Pidoplichko V. I., Opitz T., Shinozaki H. and Reymann K. G. (1994) Metabotropic glutamate receptor agonist DCG-IV as NMDA receptor agonist in immature rat hippocampal neurons. Eur. J. Pharmacol. 262, 287291.DOI: 10.1016/0014-2999(94)90743-9
  • Winder D. G. and Conn P. J. (1996) Roles of metabotropic glutamate receptors in glial function and glial-neuronal communication. J. Neurosci. Res. 46, 131137.DOI: 10.1002/(SICI)1097-4547(19961015)46:2<131::AID-JNR1>3.0.CO;2-I
  • Wisniewski K. and Car H. (2002) (S)-3,5-DHPG: a review. CNS Drug Rev. 8, 101116.
  • Zwingmann C., Richter-Landsberg C. and Leibfritz D. (2001) 13C isotopomer analysis of glucose and alanine metabolism reveals cytosolic pyruvate compartmentation as part of energy metabolism in astrocytes. Glia 34, 200212.DOI: 10.1002/glia.1054